Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Sera Prognostics, Inc. (SERA)  
$9.26 0.53 (5.41%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 29,290,000
Market Cap: 271.23(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.55 - $11.69
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Sera Prognostics is a women's health company. Co.'s primary commercial product, the PreTRM test, is a commercially available blood-based biomarker test to predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during week 19 or 20 of gestation that provides a prediction of the expectant mother's risk of delivering spontaneously before 37 weeks' gestation. Co. is discovering and developing several additional biomarker tests to predict other conditions of pregnancy, such as preeclampsia, and gestational diabetes, among others.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 8,000
Total Buy Value $0 $0 $0 $9,600
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 212,353 287,115 292,115 325,090
Total Sell Value $1,998,464 $2,554,554 $2,570,704 $2,624,320
Total People Sold 6 6 6 6
Total Sell Transactions 17 25 26 40
End Date 2024-02-13 2023-11-12 2023-05-14 2022-05-14

   
Records found: 78
  Page 2 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Aerts Austin Chief Financial Officer   •       –      –    2023-11-06 4 A $0.00 $0 D/D 335,000 340,810     -
   Boniface John J. Chief Scientific Officer   •       –      –    2023-11-06 4 A $0.00 $0 D/D 125,000 194,454     -
   Aerts Austin Chief Financial OfficerOfficer   •       –      –    2023-06-07 3 IO $0.00 $0 D/D 0 5,810 -41%     
   Harrison Robert Gardner Chief Information Officer   •       –      –    2023-06-05 4 S $3.23 $16,150 D/D (5,000) 28,500 41%     
   Kearney Paul Chief Data Officer   •       –      –    2023-04-06 4 OE $0.75 $18,038 D/D 24,050 40,050     -
   Critchfield Gregory C Chief Executive Officer   •       •      –    2023-03-07 4 A $0.00 $0 D/D 62,200 857,145     -
   Foley Michael R Chief Medical Officer   •       –      –    2023-03-06 4 A $0.00 $0 D/D 27,000 27,000     -
   Harrison Robert Gardner Chief Information Officer   •       –      –    2023-03-06 4 A $0.00 $0 D/D 28,500 28,500     -
   Altomare Nadia Chief Commercial Officer   •       –      –    2023-03-06 4 A $0.00 $0 D/D 18,300 18,300     -
   Kearney Paul Chief Data Officer   •       –      –    2023-03-06 4 A $0.00 $0 D/D 16,000 16,000     -
   Jackson Benjamin General Counsel   •       –      –    2023-03-06 4 A $0.00 $0 D/D 24,700 32,700     -
   Boniface John J. Chief Scientific Officer   •       –      –    2023-03-06 4 A $0.00 $0 D/D 22,100 69,454     -
   Moyes Jay M Chief Financial Officer   •       –      –    2023-03-06 4 A $0.00 $0 D/D 32,800 35,630     -
   Boniface John J. Chief Scientific Officer   •       –      –    2022-09-08 4 OE $0.73 $616 D/D 844 47,354     -
   Boniface John J. Chief Scientific Officer   •       –      –    2022-07-27 4 AS $2.22 $2,220 D/D (1,000) 46,510 -43%     
   Boniface John J. Chief Scientific Officer   •       –      –    2022-07-27 4 OE $0.73 $730 D/D 1,000 47,510     -
   Boniface John J. Chief Scientific Officer   •       –      –    2022-07-26 4 AS $2.15 $5,859 D/D (2,725) 46,510 -46%     
   Boniface John J. Chief Scientific Officer   •       –      –    2022-07-19 4 AS $1.86 $5,069 D/D (2,725) 49,235 -37%     
   Bxhcp Sp Iii, Llc 10% Owner   –       –       •   2022-07-18 4 D $0.00 $0 I/I (3,538,485) 46,744     -
   Boniface John J. Chief Scientific Officer   •       –      –    2022-07-12 4 AS $1.84 $5,014 D/D (2,725) 51,960 -26%     
   Boniface John J. Chief Scientific Officer   •       –      –    2022-07-05 4 AS $1.63 $4,442 D/D (2,725) 54,685 -13%     
   Boniface John J. Chief Scientific Officer   •       –      –    2022-06-29 4 AS $1.72 $1,720 D/D (1,000) 57,410 -30%     
   Boniface John J. Chief Scientific Officer   •       –      –    2022-06-29 4 OE $0.73 $730 D/D 1,000 58,410     -
   Boniface John J. Chief Scientific Officer   •       –      –    2022-06-28 4 AS $1.89 $5,150 D/D (2,725) 57,410 -32%     
   Boniface John J. Chief Scientific Officer   •       –      –    2022-06-21 4 AS $1.31 $3,570 D/D (2,725) 60,135 17%     
  78 Records found
  1  2  3  4   
  Page 2 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us